Paradoxical actions of a c-Src inhibitor on long-term ER deprived cells
If I read Lani's post correctly, this test was done on Her2+ cells (MCF-7): http://www.abstractsonline.com/Plan/...5F41EE8117E%7d
Hopeful |
Re: Paradoxical actions of a c-Src inhibitor on long-term ER deprived cells
MCF-7 cells , the most commonly used breast cancer cell line in research are her2-. Occasionally you will see studies on MCF-7 cells which are an artificial construct having been transfected (infected with additional genetic material to change them) with her2
So these cells were ER+ and her2- I have posted a list of the most common her+ cell lines used in research if you try the search function I think you'll find it I don't believe they studied what made these particular cells resistant to estrogen deprivation (and sensitive to estrogen causing apoptosis),but from previous work by these authors I don't believe they noted acquisition of her2 amplification as the cause of this change. |
All times are GMT -7. The time now is 05:52 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021